Table. Analgesic use in dialysis 6,9-11.
| Drug | Clearance | Suggested starting dose | Comments |
|---|---|---|---|
| Hydromorphone | Its major renally excreted metabolite hydromorphone-3-glucuronide is inactive | 0.5–1 mg orally 4 times a day |
Preferred oral opioid in dialysis patients |
| Oxycodone | Both oxycodone and its active metabolite oxymorphone are renally excreted | 2.5–5 mg orally 3 times a day |
Use controlled-release preparations with caution |
| Tramadol | Active renally excreted metabolite O-desmethyltramadol | 50 mg orally twice a day |
Maximum 100 mg twice a day Avoid controlled-release preparations |
| Buprenorphine | Hepatic metabolism with no accumulation of metabolites | 5 microgram/hour transdermally | Not dialysed |
| Fentanyl | Hepatic metabolism with no active metabolites | 12 microgram/hour transdermally | Not dialysed Use with caution in opioid-naïve patients |
| Gabapentin | Renal excretion | 100 mg orally at night on dialysis days |
Large dose reductions required Can treat uraemic pruritis and restless legs syndrome |
| Pregabalin | Renal excretion | 25 mg orally at night on dialysis days |
Large dose reductions required Can treat uraemic pruritis and restless legs syndrome |
| Morphine | Metabolised to renally excreted glucuronide metabolites (M-6-G and M-3-G) M-6-G is active and accumulates within the central nervous system, M-3-G lacks analgesic activity but may cause hyperalgesia and allodynia |
2.5 mg orally 3 times a day |
Avoid if possible Could be used for emergency analgesia if hydromorphone or fentanyl not immediately available |
| Codeine | Renally excreted active metabolites | – | Avoid |
| Dextro-propoxyphene | Cardiotoxic metabolite norpropoxyphene accumulates | – | Avoid |
| Paracetamol | Hepatic clearance | 1 g orally 3–4 times a day | Preferred simple analgesic |